To summarize, while it is already clear that GLP-1based therapies will be an integral part of the treatment of DKD owing to their metabolic, cardiovascular, and kidney effects, exciting times lie ahead, with the ongoing development of compounds that will have potentially greater effects on these outcomes, due to more pronounced effects on body weight and glycemia
La berberina es poderosa, pero seamos honestos: tomarla en pastillas puede ser pesado para el sistema digestivo
Weight loss from GLP-1 therapy may reduce insulin resistance and androgen levels, potentially decreasing sebum production in some individuals
A comprehensive conceptual model of the patient experience of living with ALS was developed
At Set Point Medical Weight Loss Clinic, we prioritize a comprehensive approach when it comes to treating various health conditions, like type 2 diabetes and obesity
The NIAAA AUD overview makes clear that mild and moderate AUD are real, treatable conditions, not just severe cases